10-Q Filing

Silo Pharma, Inc. CIK: 1514183 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001213900-19-015459`
Period End Date	20190630
Filing Date	20190813
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	ucut-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 72 Cash Flow Statement 41 Stockholders Equity 19

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Equity investments cost	`InvestmentOwnedAtCost`	$32.12K	USD	Point-in-time
Equity investments cost	`InvestmentOwnedAtCost`	$45.34K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.97K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$776.21K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Equity investments, at fair value (cost of $32,118 and $45,336 at June 30, 2019 and December 31, 2018, respectively)	`EquitySecuritiesFvNi`	$149.97K	USD	Point-in-time
Equity investments, at fair value (cost of $32,118 and $45,336 at June 30, 2019 and December 31, 2018, respectively)	`EquitySecuritiesFvNi`	$215.53K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$12.77K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$12.77K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, per share redemption value	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, per share redemption value	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$34.03K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.42K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$26.97K	USD	Point-in-time
Inventory	`InventoryNet`	$26.97K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$625.98K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$306.10K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Note receivable, net	`NotesAndLoansReceivableNetNoncurrent`	$200.00K	USD	Point-in-time
Note receivable, net	`NotesAndLoansReceivableNetNoncurrent`	$200.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	$29.44K	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	$29.44K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.42M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.47M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.47M	shares	Point-in-time
Total Other Assets	`AssetsNoncurrent`	$229.44K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.42M	shares	Point-in-time
Total Other Assets	`AssetsNoncurrent`	$229.44K	USD	Point-in-time
Total Assets	`Assets`	$535.54K	USD	Point-in-time
Total Assets	`Assets`	$855.42K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.63K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.52K	USD	Point-in-time
Insurance finance loan	`InsuranceFinanceLoanCurrent`	$5.08K	USD	Point-in-time
Insurance finance loan	`InsuranceFinanceLoanCurrent`	$22.34K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$47.98K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$32.59K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, $0.0001 par value, 1,000,000 shares shares designated; 4,000 shares issued and outstanding at June 30, 2019 and December 31, 2018 ($100 per share redemption value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, $0.0001 par value, 1,000,000 shares shares designated; 4,000 shares issued and outstanding at June 30, 2019 and December 31, 2018 ($100 per share redemption value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 23,467,540 and 23,417,450 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$2.35K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 23,467,540 and 23,417,450 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$2.34K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.11M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.05M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.01M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$407.44K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$292.67K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$904.68K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$1.20M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$1.22M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$102.94K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$535.54K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$855.42K	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	2 Qtrs
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	2 Qtrs
Compensation expense	`ShareBasedCompensation`	$116.24K	USD	2 Qtrs
Compensation expense	`ShareBasedCompensation`	$40.00K	USD	1 Quarter
Compensation expense	`ShareBasedCompensation`	$86.24K	USD	1 Quarter
Compensation expense	`ShareBasedCompensation`	$85.00K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$78.12K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$206.22K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$18.52K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$94.72K	USD	2 Qtrs
Insurance expense	`GeneralInsuranceExpense`	$8.17K	USD	1 Quarter
Insurance expense	`GeneralInsuranceExpense`	$8.80K	USD	1 Quarter
Insurance expense	`GeneralInsuranceExpense`	$16.35K	USD	2 Qtrs
Insurance expense	`GeneralInsuranceExpense`	$17.60K	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-1.50K	USD	1 Quarter
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-5.50K	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-5.00K	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.79K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$18.84K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.13K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$18.64K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$364.44K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$76.11K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$189.87K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$210.96K	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-210.96K	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-364.44K	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-76.11K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-189.87K	USD	1 Quarter
Interest income	`InvestmentIncomeNet`	$18.00	USD	1 Quarter
Interest income	`InvestmentIncomeNet`	$6.05K	USD	2 Qtrs
Interest income	`InvestmentIncomeNet`	$3.04K	USD	1 Quarter
Interest income	`InvestmentIncomeNet`	$26.00	USD	2 Qtrs
Interest expense	`InterestExpense`	$316.00	USD	1 Quarter
Interest expense	`InterestExpense`	$770.00	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Net realized gain on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$521.47K	USD	2 Qtrs
Net realized gain on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$45.77K	USD	2 Qtrs
Net realized gain on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$45.77K	USD	1 Quarter
Net realized gain on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$287.22K	USD	1 Quarter
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-52.34K	USD	2 Qtrs
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-527.05K	USD	1 Quarter
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-608.90K	USD	2 Qtrs
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-100.83K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-87.40K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-52.34K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-239.81K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.29K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-298.37K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-365.73K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-315.91K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-242.21K	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	23.44M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	50.08M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	23.43M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	50.08M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.08M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.43M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.44M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.08M	shares	1 Quarter

Cash Flow Statement 41 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-298.37K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-365.73K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-315.91K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-242.21K	USD	1 Quarter
Stock-based compensation	`AllocatedStockbasedCompensation`	-	USD	2 Qtrs
Stock-based compensation	`AllocatedStockbasedCompensation`	$61.24K	USD	2 Qtrs
Net realized gain on equity investments	`RealizedInvestmentGainsLosses`	$45.77K	USD	2 Qtrs
Net realized gain on equity investments	`RealizedInvestmentGainsLosses`	$521.47K	USD	2 Qtrs
Net unrealized (gain) loss on equity investments	`UnrealizedGainLossOnInvestments`	$-608.90K	USD	2 Qtrs
Net unrealized (gain) loss on equity investments	`UnrealizedGainLossOnInvestments`	$-52.34K	USD	2 Qtrs
Proceeds from sale of equity investments	`GainLossOnSaleOfInvestments`	$-679.68K	USD	2 Qtrs
Proceeds from sale of equity investments	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
Bad debt recovery	`BadDebtRecovery`	-	USD	2 Qtrs
Bad debt recovery	`BadDebtRecovery`	$5.00K	USD	2 Qtrs
(Increase) decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-11.10K	USD	2 Qtrs
(Increase) decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$5.39K	USD	2 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$6.78K	USD	2 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.89K	USD	2 Qtrs
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-301.43K	USD	2 Qtrs
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$481.62K	USD	2 Qtrs
Proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$58.99K	USD	2 Qtrs
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$58.99K	USD	2 Qtrs
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	$17.27K	USD	2 Qtrs
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	-	USD	2 Qtrs
NET CASH USED IN FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-17.27K	USD	2 Qtrs
NET CASH USED IN FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS:	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-259.71K	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS:	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$481.62K	USD	2 Qtrs
CASH AND CASH EQUIVALENTS - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$76.97K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$776.21K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of period	`CashAndCashEquivalentsAtCarryingValue`	$76.97K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of period	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of period	`CashAndCashEquivalentsAtCarryingValue`	$776.21K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of period	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	2 Qtrs
Interest	`InterestPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$407.44K	USD	Point-in-time
Balance	`StockholdersEquity`	$292.67K	USD	Point-in-time
Balance	`StockholdersEquity`	$904.68K	USD	Point-in-time
Balance	`StockholdersEquity`	$1.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Balance	`StockholdersEquity`	$102.94K	USD	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$8.75K	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$8.75K	USD	1 Quarter
Net (decrease) increase in net assets resulting from operations	`StockIssuedDuringPeriodNetDecreaseIncreaseInNetAssetsResultingFromOperations`	$17.55K	USD	1 Quarter
Net (decrease) increase in net assets resulting from operations	`StockIssuedDuringPeriodNetDecreaseIncreaseInNetAssetsResultingFromOperations`	$-315.91K	USD	1 Quarter
Accretion of stock options for services	`StockIssueDuringPeriodAccretionOfStockOptionsForServices`	$43.74K	USD	1 Quarter
Net loss	`ProfitLoss`	$-242.21K	USD	1 Quarter
Net loss	`ProfitLoss`	$-123.52K	USD	1 Quarter
Balance	`StockholdersEquity`	$407.44K	USD	Point-in-time
Balance	`StockholdersEquity`	$292.67K	USD	Point-in-time
Balance	`StockholdersEquity`	$904.68K	USD	Point-in-time
Balance	`StockholdersEquity`	$1.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Balance	`StockholdersEquity`	$102.94K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.